12 days agoRegenerative Med & Tissue Bioengineering Thought Leader Stream - Progress, Potential & PossibilitiesProgressPotentialAndPossibilities
2 years agoNavy Will Sign Contract This Month-NApAnt Is Expected To Be Delivered To The Navy In Three Years.MinhaPatriaSuaPatria
1 year agoDr. Marco Quarta, Ph.D. - Co-Founder and CEO - Rubedo Life Sciences; CEO, The Phaedon InstituteProgressPotentialAndPossibilities